According to a recent report by SNS Insider, the PARP Inhibitor Biomarkers Market has been experiencing steady growth, valued at USD 901.25 million in 2023, and is forecasted to nearly double by reaching USD 1892.80 million by 2032, expanding at a compound annual growth rate (CAGR) of 8.64% over the forecast period. This growth is primarily fueled by the rising...